References: Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Arlington, VA. American Psychiatric Association. https://doi.org/10.1176/appi.books.9780890425596 (2013).
Savatt, J. M. & Myers, S. M. Genetic testing in neurodevelopmental disorders. Front. Pediatr. 9, 526779 (2021). (PMID: 33681094793379710.3389/fped.2021.526779)
Tărlungeanu, D. C. & Novarino, G. Genomics in neurodevelopmental disorders: An avenue to personalized medicine. Exp. Mol. Med. 50, 1–7 (2018). (PMID: 3008984010.1038/s12276-018-0129-7)
Yao, F. et al. Protein biomarkers of autism spectrum disorder identified by computational and experimental methods. Front. Psych. 12, 554621 (2021). (PMID: 10.3389/fpsyt.2021.554621)
Yasui, Y. A data-analytic strategy for protein biomarker discovery: Profiling of high-dimensional proteomic data for cancer detection. Biostatistics 4, 449–463 (2003). (PMID: 1292551110.1093/biostatistics/4.3.449)
Murtaza, N., Uy, J. & Singh, K. K. Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders. Mol. Autism 11, 27 (2020). (PMID: 32317014717183910.1186/s13229-020-00334-5)
Iwase, K. et al. The secretogranin II gene is a signal integrator of glutamate and dopamine inputs. J. Neurochem. 128, 233–245 (2014). (PMID: 2411198410.1111/jnc.12467)
Kim, H. J. et al. REST regulates non–cell-autonomous neuronal differentiation and maturation of neural progenitor cells via secretogranin II. J. Neurosci. 35, 14872–14884 (2015). (PMID: 26538656463513410.1523/JNEUROSCI.4286-14.2015)
Mattsson, N. et al. Cerebrospinal fluid concentrations of peptides derived from chromogranin B and secretogranin II are decreased in multiple sclerosis. J. Neurochem. 103, 1932–1939 (2007). (PMID: 1795365510.1111/j.1471-4159.2007.04985.x)
Duits, F. H. et al. Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease. Alzheimers. Res. Ther. 10, 5 (2018). (PMID: 29370833638907310.1186/s13195-017-0335-x)
Saylan, Y., Akgönüllü, S. & Denizli, A. Plasmonic sensors for monitoring biological and chemical threat agents. Biosensor 10, 142 (2020). (PMID: 10.3390/bios10100142)
de la Rica, R. & Stevens, M. M. Plasmonic ELISA for the ultrasensitive detection of disease biomarkers with the naked eye. Nat. Nanotechnol. 7, 821–824 (2012). (PMID: 2310393510.1038/nnano.2012.186)
Scott, M. et al. Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat. Commun. 2, 466 (2012).
Li, M., Cushing, S. K. & Wu, N. Plasmon-enhanced optical sensors: A review. Analyst 140, 386 (2015). (PMID: 25365823427427110.1039/C4AN01079E)
Mayer, K. M. et al. A label-free immunoassay based upon localized surface plasmon resonance of gold nanorods. ACS Nano 2, 687–692 (2008). (PMID: 1920659910.1021/nn7003734)
Endo, T., Kerman, K., Nagatani, N., Takamura, Y. & Tamiya, E. Label-free detection of peptide nucleic acid-DNA hybridization using LSPR based optical biosensor. Anal. Chem. 77, 6976–6984 (2005). (PMID: 1625559810.1021/ac0513459)
Mock, J. J., Smith, D. R. & Schultz, S. Local refractive index dependence of plasmon resonance spectra from individual nanoparticles. Nano Lett. 3, 485–491 (2003). (PMID: 10.1021/nl0340475)
Raschke, G. et al. Biomolecular recognition based on single gold nanoparticle light scattering. Nano Lett. 3, 935–938 (2003). (PMID: 10.1021/nl034223+)
Park, J. H., Byun, J. Y., Jang, H., Hong, D. & Kim, M. G. A highly sensitive and widely adaptable plasmonic aptasensor using berberine for small-molecule detection. Biosens. Bioelectron. 97, 292–298 (2017). (PMID: 2861836510.1016/j.bios.2017.06.019)
Haes, A. J. & Van Duyne, R. P. A nanoscale optical biosensor: Sensitivity and selectivity of an approach based on the localized surface plasmon resonance spectroscopy of triangular silver nanoparticles. J. Am. Chem. Soc. 124, 10596–10604 (2002). (PMID: 1219776210.1021/ja020393x)
Jo, N., Lee, K. & Shin, Y. B. Enzyme-coupled nanoplasmonic biosensing of cancer markers in human serum. Biosens. Bioelectron. 81, 324–333 (2016). (PMID: 2698558510.1016/j.bios.2016.03.009)
Jo, N. & Shin, Y. B. Enhancing biosensing sensitivity of metal nanostructures through site selective binding. Sci. Rep. 10, 1024 (2020). (PMID: 31974422697845910.1038/s41598-020-57791-4)
Lee, S. W. et al. Highly sensitive biosensing using arrays of plasmonic Au nanodisks realized by nanoimprint lithography. ACS Nano 5, 897–904 (2011). (PMID: 2122248710.1021/nn102041m)
Faget, L. & Hnasko, T. S. Tyramide signal amplification for immunofluorescent enhancement. In: Hnasko R. (eds) ELISA. Methods in Molecular Biology, vol. 1318. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-2742-5_16 (2015).
Stack, E. C., Wang, C., Roman, K. A. & Hoyt, C. C. Multiplexed immunohistochemistry, imaging, and quantitation: A review, with an assessment of tyramide signal amplification, multispectral imaging and multiplex analysis. Methods 70, 46–58 (2014). (PMID: 2524272010.1016/j.ymeth.2014.08.016)
Akama, K., Shirai, K. & Suzuki, S. Droplet-Free digital enzyme-linked immunosorbent assay based on a tyramide signal amplification system. Anal. Chem. 88, 7123–7129 (2016). (PMID: 2732252510.1021/acs.analchem.6b01148)
Fu, C. et al. Catalyzed deposition of signal reporter for highly sensitive surface-enhanced Raman spectroscopy immunoassay based on tyramine signal amplification strategy. Anal. Chem. 90, 13159–13162 (2018). (PMID: 3026456110.1021/acs.analchem.8b02419)
Li, X., Chen, B., He, M., Xiao, G. & Hu, B. Gold nanoparticle labeling with tyramide signal amplification for highly sensitive detection of alpha fetoprotein in human serum by ICP-MS. Talanta 176, 40–46 (2018). (PMID: 2891776810.1016/j.talanta.2017.08.007)
Lim, S. H. et al. Synapse formation regulated by protein tyrosine phosphatase receptor T through interaction with cell adhesion molecules and Fyn. EMBO J. 28, 3564–3578 (2009). (PMID: 19816407278210010.1038/emboj.2009.289)
Lim, S. H. et al. Depression-like behaviors induced by defective PTPRT activity through dysregulated synaptic functions and neurogenesis. J. Cell Sci. 133, jcs243972 (2020). (PMID: 3293868410.1242/jcs.243972)
Schuurs-Hoeijmakers, J. H. et al. Identification of pathogenic gene variants in small families with intellectually disabled siblings by exome sequencing. J. Med. Genet. 50, 802–811 (2013). (PMID: 2412387610.1136/jmedgenet-2013-101644)
Quintela, I. et al. Copy number variation analysis of patients with intellectual disability from North-West Spain. Gene 626, 189–199 (2017). (PMID: 2850674810.1016/j.gene.2017.05.032)
Allen-Brady, K. et al. A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol. Psychiat. 14, 590–600 (2009). (PMID: 10.1038/mp.2008.14)
Aston, C., Jiang, L. & Sokolov, B. P. Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder. Mol. Psychiat. 10, 309–322 (2005). (PMID: 10.1038/sj.mp.4001565)
Zablotsky, B. et al. Prevalence and trends of developmental disabilities among children in the United States: 2009–2017. Pediatrics 144, e20190811 (2019). (PMID: 3155857610.1542/peds.2019-0811)
Xu, D. J., Wei, L. Y., Li, H. F. & Zhang, W. Q. Serum levels of chromogranins and secretogranins correlate with the progress and severity of Parkinson’s disease. Kaohsiung J. Med. Sci. 35, 146–150 (2019). (PMID: 3088772410.1002/kjm2.12026)
Neul, J. L. et al. Metabolic signatures differentiate Rett syndrome from unaffected siblings. Front. Integr. Neurosci. 14, 7 (2020). (PMID: 32161522705237510.3389/fnint.2020.00007)
McLane, R. D. et al. Peripheral amyloid precursor protein derivative expression in fragile x syndrome. Front. Integr. Neurosci. 13, 49 (2019). (PMID: 31551722673399310.3389/fnint.2019.00049)
Sahin, M., Sweeney, J. & Jones, S. R. Biomarkers to enable therapeutics development in neurodevelopmental disorders. Front. Integr. Neurosci. 14, 616641 (2020). (PMID: 33262695768657510.3389/fnint.2020.616641)
Shyu, W. C. et al. Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J. Clin. Invest. 118, 133–148 (2008). (PMID: 1807996610.1172/JCI32723)
Kennedy, M. B. Synaptic signaling in learning and memory. Cold Spring Harb. Perspect. Biol. 8, a016824 (2016). (PMID: 474308210.1101/cshperspect.a016824)
Kim, Y. J. et al. STEP signaling pathway mediates psychomotor stimulation and morphine withdrawal symptoms, but not for reward, analgesia and tolerance. Exp. Mol. Med. 48, e212 (2016). (PMID: 26915673489288010.1038/emm.2016.1)
Nakayama, A., Harms, M. & Luo, L. Small GTPases Rac and Rho in the maintenance of dendritic spines and brainches in hippocampal pyramidal neurons. J. Neurosci. 20, 5329–5339 (2000). (PMID: 10884317677233410.1523/JNEUROSCI.20-14-05329.2000)
No Comments.